Review of spasticity medicines
at least annually once the optimal dose has been reached
tests per year, UK, at least annually once the optimal dose has been reached
“have their medicines reviewed at least annually once the optimal dose has been reached.”
NICE NG220, Multiple sclerosis in adults: management, spasticity, 2022-06
- Kind of source
- Clinical guideline
- Read on
- 2026-11-06
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- Applies to people taking baclofen or gabapentin for spasticity.
Used in
Kept as evidence; no figure on the platform is computed from it yet.